




Searching News Database: FFPE
HSMN NewsFeed - 13 Jan 2025
Roche receives FDA clearance for new, highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma
Roche receives FDA clearance for new, highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma
HSMN NewsFeed - 24 Oct 2024
Pillar Biosciences Receives CPT(R) Code for FDA Approved oncoReveal(TM) CDx Pan-Cancer Solid tumor IVD Kit
Pillar Biosciences Receives CPT(R) Code for FDA Approved oncoReveal(TM) CDx Pan-Cancer Solid tumor IVD Kit
HSMN NewsFeed - 15 Jun 2020
Epredia and Lunaphore Announce Commercial Agreement for Exclusive Distribution of LabSat(R) Research
Epredia and Lunaphore Announce Commercial Agreement for Exclusive Distribution of LabSat(R) Research
HSMN NewsFeed - 28 Jun 2018
Thermo Fisher Scientific Expands Oncomine Immuno-Oncology Assay Portfolio
Thermo Fisher Scientific Expands Oncomine Immuno-Oncology Assay Portfolio
HSMN NewsFeed - 26 Jul 2017
Roche Launches the Avenio Millisect System for Precise and Efficient Dissection of Tissue Biopsies
Roche Launches the Avenio Millisect System for Precise and Efficient Dissection of Tissue Biopsies
HSMN NewsFeed - 12 Apr 2017
Roche Launches Antibody Test to Aid in Diagnosis of Challenging Prostate Cancer Cases
Roche Launches Antibody Test to Aid in Diagnosis of Challenging Prostate Cancer Cases
HSMN NewsFeed - 20 Feb 2017
DiaCarta Receives CE-IVD for its Non-Invasive Colorectal Cancer Test - ColoScape(TM) Real-Time PCR Kit
DiaCarta Receives CE-IVD for its Non-Invasive Colorectal Cancer Test - ColoScape(TM) Real-Time PCR Kit
HSMN NewsFeed - 17 Feb 2014
Published Study Validates Agendia’s MammaPrint Test for Long-Term Prediction of Breast Cancer Outcome
Published Study Validates Agendia’s MammaPrint Test for Long-Term Prediction of Breast Cancer Outcome
HSMN NewsFeed - 9 Jul 2012
Agendia Names Industry Veteran Glen Fredenberg CFO and Vice President of Finance
Agendia Names Industry Veteran Glen Fredenberg CFO and Vice President of Finance
HSMN NewsFeed - 8 Jul 2008
Monogram Announces Commercial Availability of the HERmark(TM) Breast Cancer Assay
Monogram Announces Commercial Availability of the HERmark(TM) Breast Cancer Assay
HSMN NewsFeed - 25 Apr 2007
Celera and LabCorp(R) Announce Licensing Agreement to Commercialize Breast Cancer Testing Assays
Celera and LabCorp(R) Announce Licensing Agreement to Commercialize Breast Cancer Testing Assays
HSMN NewsFeed - 22 Feb 2007
Celera Presents Data Validating Its Metastasis Score as a Molecular Prognostic Tool in Breast Cancer
Celera Presents Data Validating Its Metastasis Score as a Molecular Prognostic Tool in Breast Cancer
Additional items found! 1

Members Archive contains
1 additional stories matching:
FFPE
(Password required)
FFPE
(Password required)